CoChat

Pancreatic Islet-Specific Expression of an Insulin-Like Growth Factor-I Transgene Compensates Islet Cell Growth in Growth Hormone Receptor Gene-Deficient Mice

Guo, Yubin, Lu, Yarong, Houle, Daniel, Robertson, Katie, Tang, Zhengyi, Kopchick, John J., Liu, Ye Lauren, Liu, Jun-Li · 2005 · Endocrinology
Cited by 60

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Both GH and IGF-I stimulate islet cell growth, inhibit cell apoptosis, and regulate insulin biosynthesis and secretion. GH receptor gene deficiency (GHR(-/-)) caused diminished pancreatic islet cell mass and serum insulin level and elevated insulin sensitivity. Because IGF-I gene expression was nearly abolished in these mice, we sought to determine whether that had caused the islet defects. To restore IGF-I level, we have generated transgenic mice that express rat IGF-I cDNA under the direction of rat insulin promoter 1 (RIP-IGF). Using RNase protection assay and immunohistochemistry, the IGF-I transgene expression was revealed specifically in pancreatic islets of the RIP-IGF mice, which exhibited normal growth and development and possess no abnormalities in glucose homeostasis, insulin production, and islet cell mass. GHR(-/-) mice exhibited 50% reduction in the ratio of islet cell mass to body weight and increased insulin sensitivity but impaired glucose tolerance. Compared with GHR(-/-) alone, IGF-I overexpression on a GHR(-/-) background caused no change in the diminished blood glucose and serum insulin levels, pancreatic insulin contents, and insulin tolerance but improved glucose tolerance and insulin secretion. Remarkably, islet-specific overexpression of IGF-I gene in GHR(-/-) mice restored islet cell mass, at least partially through cell hypertrophy. Interestingly, double-transgenic male mice demonstrated a transient rescue in growth rates vs. GHR(-/-) alone, at 2-3 months of age. Our results suggest that IGF-I deficiency is part of the underlying mechanism of diminished islet growth in GHR(-/-) mice and are consistent with the notion that IGF-I mediates GH-induced islet cell growth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2004-1203

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 43

  1. Le Roith, 2001, The somatomedin hypothesis: 2001, Endocr Rev, 22, 53, 10.1210/edrv.22.1.0419 · DOI · Paper page
  2. Nielsen, 1990, Expression of the growth hormone receptor gene in insulin producing cells, Biomed Biochim Acta, 49, 1151
  3. Fehmann, 1996, Functional active receptors for insulin-like growth factors-I (IGF-I) and IGF-II on insulin-, glucagon-, and somatostatin-producing cells, Metabolism, 45, 759, 10.1016/S0026-0495(96)90143-2 · DOI
  4. Nielsen, 1989, Growth hormone is a growth factor for the differentiated pancreatic β-cell, Mol Endocrinol, 3, 165, 10.1210/mend-3-1-165 · DOI · Paper page
  5. Hugl, 1998, Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells, J Biol Chem, 273, 17771, 10.1074/jbc.273.28.17771 · DOI · Paper page
  6. Harrison, 1998, Growth factor protection against cytokine-induced apoptosis in neonatal rat islets of Langerhans: role of Fas, FEBS Lett, 435, 207, 10.1016/S0014-5793(98)01051-5 · DOI
  7. Dominici, 2000, Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice, J Endocrinol, 166, 579, 10.1677/joe.0.1660579 · DOI · Paper page
  8. Liu, 2004, Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice, Am J Physiol Endocrinol Metab, 287, E405, 10.1152/ajpendo.00423.2003 · DOI · Paper page
  9. Zhou, 1997, A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse), Proc Natl Acad Sci USA, 94, 13215, 10.1073/pnas.94.24.13215 · DOI · Paper page
  10. Devedjian, 2000, Transgenic mice overexpressing insulin-like growth factor-II in β cells develop type 2 diabetes, J Clin Invest, 105, 731, 10.1172/JCI5656 · DOI · Paper page
  11. Valera, 1994, Expression of GLUT-2 antisense RNA in β cells of transgenic mice leads to diabetes, J Biol Chem, 269, 28543, 10.1016/S0021-9258(19)61937-X · DOI · Paper page
  12. Neuenschwander, 1996, Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model, J Clin Invest, 97, 2225, 10.1172/JCI118663 · DOI · Paper page
  13. Chandrashekar, 1999, Pituitary and testicular function in growth hormone receptor gene knockout mice, Endocrinology, 140, 1082, 10.1210/endo.140.3.6557 · doi:10.1210/endo.140.3.6557 · Paper page
  14. Miao, 2001, Osteomalacia in Hyp mice is associated with abnormal Phex expression and with altered bone matrix protein expression and deposition, Endocrinology, 142, 926, 10.1210/endo.142.2.7976 · DOI · Paper page
  15. Hsu, 1981, Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures, J Histochem Cytochem, 29, 577, 10.1177/29.4.6166661 · DOI · Paper page
  16. Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2 · DOI · Paper page
  17. Vasavada, 1996, Overexpression of parathyroid hormone-related protein in the pancreatic islets of transgenic mice causes islet hyperplasia, hyperinsulinemia, and hypoglycemia, J Biol Chem, 271, 1200, 10.1074/jbc.271.2.1200 · DOI · Paper page
  18. Liu, 1998, Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice, Mol Endocrinol, 12, 1452, 10.1210/mend.12.9.0162 · DOI · Paper page
  19. Rosenau, 2002, Development of a chemiluminescence-based ribonuclease protection assay, Biotechniques, 33, 1354, 10.2144/02336pf02 · DOI
  20. Kulkarni, 1999, Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes, Cell, 96, 329, 10.1016/S0092-8674(00)80546-2 · DOI · Paper page
  21. George, 2002, β-Cell expression of IGF-I leads to recovery from type 1 diabetes, J Clin Invest, 109, 1153, 10.1172/JCI0212969 · DOI · Paper page
  22. Rhodes, 2000, IGF-I and GH post-receptor signaling mechanisms for pancreatic β-cell replication, J Mol Endocrinol, 24, 303, 10.1677/jme.0.0240303 · DOI · Paper page
  23. Dominici, 2002, Growth hormone-induced alterations in the insulin-signaling system, Exp Biol Med (Maywood), 227, 149, 10.1177/153537020222700301 · DOI
  24. Okuda, 2001, Acute effects of growth hormone on metabolism of pancreatic hormones, glucose and ketone bodies, Diabetes Res Clin Pract, 53, 1, 10.1016/S0168-8227(01)00232-7 · DOI
  25. Nielsen, 2001, Regulation of β-cell mass by hormones and growth factors, Diabetes, 50, S25, 10.2337/diabetes.50.2007.S25 · DOI · Paper page
  26. Rabinovitch, 1983, Growth hormone stimulates islet B-cell replication in neonatal rat pancreatic monolayer cultures, Diabetes, 32, 307, 10.2337/diab.32.4.307 · DOI
  27. Galsgaard, 1996, Identification of a growth hormone-responsive STAT5-binding element in the rat insulin 1 gene, Mol Endocrinol, 10, 652
  28. Galsgaard, 1999, Regulation of prolactin receptor (PRLR) gene expression in insulin-producing cells. Prolactin and growth hormone activate one of the rat prlr gene promoters via STAT5a and STAT5b, J Biol Chem, 274, 18686, 10.1074/jbc.274.26.18686 · DOI · Paper page
  29. Sims, 2000, Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5, J Clin Invest, 106, 1095, 10.1172/JCI10753 · DOI · Paper page
  30. Bachelot, 2002, Growth hormone is required for ovarian follicular growth, Endocrinology, 143, 4104, 10.1210/en.2002-220087 · DOI · Paper page
  31. Swenne, 1989, Growth hormone regulation of DNA replication, but not insulin production, is partly mediated by somatomedin-C/insulin-like growth factor I in isolated pancreatic islets from adult rats, Diabetologia, 32, 191, 10.1007/BF00265093 · DOI
  32. Hill, 1991, Growth factor control of pancreatic B cell hyperplasia, Baillieres Clin Endocrinol Metab, 5, 689, 10.1016/S0950-351X(10)80010-2 · DOI
  33. Maake, 1993, Immunohistochemical localization of insulin-like growth factor 1 and 2 in the endocrine pancreas of rat, dog, and man, and their coexistence with classical islet hormones, Cell Tissue Res, 273, 249, 10.1007/BF00312826 · DOI
  34. Portela-Gomes, 2000, Insulin-like growth factor II in human fetal pancreas and its co-localization with the major islet hormones: comparison with adult pancreas, J Endocrinol, 165, 245, 10.1677/joe.0.1650245 · DOI
  35. Hill, 2000, Increased and persistent circulating insulin-like growth factor II in neonatal transgenic mice suppresses developmental apoptosis in the pancreatic islets, Endocrinology, 141, 1151, 10.1210/endo.141.3.7354 · DOI
  36. Xuan, 2002, Defective insulin secretion in pancreatic β-cells lacking type 1 IGF receptor, J Clin Invest, 110, 1011, 10.1172/JCI0215276 · doi:10.1172/jci0215276 · Paper page
  37. Kulkarni, 2002, β-Cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass, Nat Genet, 31, 111, 10.1038/ng872 · DOI · Paper page
  38. Yakar, 2001, Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity, Diabetes, 50, 1110, 10.2337/diabetes.50.5.1110 · DOI · Paper page
  39. Zhao, 2004, Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice, J Clin Invest, 113, 96, 10.1172/JCI200417763 · DOI
  40. Yu, 2003, Liver-specific IGF-I gene deficient mice exhibit accelerated diabetes in response to streptozotocin, associated with early onset of insulin resistance, Mol Cell Endocrinol, 204, 31, 10.1016/S0303-7207(03)00145-X · DOI
  41. Lu, 2004, Pancreatic specific inactivation of IGF-I gene causes enlarged pancreatic islets and significant resistance to diabetes, Diabetes, 53, 3131, 10.2337/diabetes.53.12.3131 · DOI · Paper page
  42. Billestrup, 1991, The stimulatory effect of growth hormone, prolactin, and placental lactogen on β-cell proliferation is not mediated by insulin-like growth factor-I, Endocrinology, 129, 883, 10.1210/endo-129-2-883 · DOI · Paper page
  43. Cousin, 1999, Stimulation of pancreatic β-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling, Biochem J, 344, 649, 10.1042/bj3440649 · doi:10.1042/bj3440649

Cited by

See all 60

Metadata

Authors
Guo, Y., Lu, Y., Houle, D., Robertson, K., Tang, Z., Kopchick, J. J., Liu, Y. L., & Liu, J.-L.
Venue
Endocrinology
Published
2005-06-01
Volume
146
Issue
6
Pages
2602-2609
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2061634582
Cited by
60
References
4
FWCI
4.41
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.